Related Experiment Video
Updated: Jul 8, 2026
04:01
Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures
Published on: June 23, 2023
Modeling therapy resistance in genetically engineered mouse cancer models.
1Division of Molecular Biology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.
Summary
Genetically engineered mouse models offer a powerful in vivo approach to understand cancer drug resistance mechanisms. These models help identify how tumors develop resistance and guide the optimization of new cancer therapies.
Area of Science:
- Oncology
- Pharmacology
- Translational Medicine
Background:
- Drug resistance is a significant challenge in cancer treatment, impacting both traditional chemotherapy and targeted therapies.
- Current understanding of specific drug resistance mechanisms in patients remains incomplete, hindering effective strategy development.
- Genetically engineered mouse models (GEMMs) that mimic human cancers offer a promising platform for in vivo research.
Purpose of the Study:
- To highlight the utility of GEMMs for investigating in vivo mechanisms of anti-cancer drug resistance.
- To explore the application of GEMMs in analyzing intrinsic and acquired resistance.
- To demonstrate the potential of GEMMs for characterizing residual cancer cells post-treatment.
Main Methods:
- Utilizing genetically engineered mouse models that develop human-like tumors.
- Analyzing intrinsic and acquired drug resistance mechanisms within these models.
- Characterizing residual tumor cells that survive anti-cancer drug treatment.
Main Results:
- GEMMs provide a relevant in vivo system to study complex drug resistance phenomena.
- These models allow for the detailed investigation of how cancer cells become resistant to therapies.
- Residual cells surviving treatment can be identified and studied in a physiologically relevant context.
Conclusions:
- Genetically engineered mouse models are valuable tools for elucidating in vivo cancer drug resistance mechanisms.
- These models facilitate the study of both initial and developing resistance, as well as treatment survivors.
- Optimization of drug regimens and combinations can be effectively performed in GEMMs before clinical application.
Related Concept Videos
02:43Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
02:43Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
01:16In-vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.